This user guide is intended to support better measurement and understanding of the pathways and key factors involved in the launch and scale of health interventions in LMICs.
In response to the COVID-19 pandemic, unprecedented public and private investments and collaborations accelerated the research, development, manufacturing, and distribution of new interventions, especially safe and effective vaccines.
In this brief, we highlight the challenges in controlling the monkeypox outbreak in global and US contexts and provide practical recommendations and lessons from the COVID-19 pandemic. This issue brief will focus primarily on analysis of the monkeypox vaccine marketplace as an urgent and pressing challenge.
This report examines successes and pain points of the World Health Organization’s (WHO) Prequalification (PQ) Program and offers actionable recommendations to strengthen its role in facilitating global access to medical products.
A report describing the application of the Speedometer framework to analyze select interventions that address maternal, newborn, and child health. In addition to analyzing and reporting on launch and scale trends and patterns for these interventions, this report provides recommendations for the community of funders and policymakers to enable proven interventions to reach more people rapidly.
New and enduring global health challenges need effective, proven solutions and interventions that can be scaled to reach the most vulnerable populations.
This case study is part of a series that explores pathways and important factors that contribute to the development and uptake of global health interventions - from proof of concept to scale-up.
This case study is part of a series that explores pathways and important factors that contribute to the development and uptake of global health interventions - from proof of concept to scale-up.
A call to action for world leaders to convene a "Global Pandemic Response and Vaccination Summit" to create a coordinated, global response to the pandemic.
The COVID-19 vaccine manufacturing landscape is highly dynamic, both expanding and contracting almost daily. This issue brief is the first analysis of publicly available information about COVID vaccine manufacturing. Updated data available.